Compare Novavax Inc (NVAX) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Energy Select Sector SPDR Fund — how do they compare? Novavax Inc trades at $12.29 (market cap $1.82B), while Energy Select Sector SPDR Fund trades at $65.44 (market cap $40.84B). The key difference: Energy Select Sector SPDR Fund is far larger — about 22.4× Novavax Inc's market cap, and Energy Select Sector SPDR Fund is more actively traded (50,409,268 versus 6,198,505). Which is the better fit depends on your goals — on Pluang, investors hold Novavax Inc for 59 Days and Energy Select Sector SPDR Fund for 67 Days on average.
| NVAX | XLE | |
|---|---|---|
Market Cap | $1.82B | $40.84B |
Volume | 6,198,505 | 50,409,268 |
Sector | Health | — |
52-Week High | $12.56 | $65.93 |
52-Week Low | $6.22 | $42.61 |
Typical Hold Time | 59 Days | 67 Days |
Enterprise Value | $1.39B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $11.22, down 0.88% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company reported strong revenue of $1.12 billion in 2025 and a net income of $440.30 million, but faces negative cash flow and a projected net loss for 2026. Recent news highlights its strategic pivot to a partnership-driven model using its Matrix-M adjuvant technology, with regulatory approvals for its updated COVID-19 vaccine in key markets.
The outlook for NVAX is mixed, with analyst consensus strongly favoring a buy rating (73.92%) but significant financial risks including negative equity, persistent cash burn, and volatile earnings. Investment opportunity lies in the successful execution of its licensing strategy and expansion into oncology, though execution risks and competitive pressures remain key concerns for shareholders.
XLE (Energy Select Sector SPDR ETF) trades at $65.46, up 3.28% with strong bullish momentum from moving averages but overbought RSI signals. The ETF faces mixed sentiment as oil prices surge above $100 amid Middle East tensions while futures traders bet on a 12% energy sector decline. Recent news highlights strategic oil reserve concerns and diesel price pressures, creating volatility in energy markets.
Outlook remains volatile with geopolitical risks and Fed policy influencing energy prices. The ETF's 91% oil and gas concentration offers pure energy exposure but amplifies crude price sensitivity. Key risks include oil price reversals and export restrictions, while institutional flows into midstream ETFs suggest defensive positioning within the sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
